Manipulation of neural activity in genetically predefined populations of neurons through genetic techniques is an essential tool in the field of neuroscience as well as a potential avenue in treating a vast assortment of neurological and psychiatric diseases. Here, we describe an emerging methodology of molecular neuromodulation termed bioluminescence-optogenetics (BL-OG) where BL is harnessed to activate bacterial light-driven channels and pumps expressed in neurons to control their activity. BL-OG is realized through opsin-luciferase fusion proteins called luminopsins (LMOs). In this chapter, we will provide a practical guide for applying BL-OG and LMOs in vitro using a cell line and primary cells in culture. In the following chapter, we will turn our focus towards BL-OG applications in ex vivo and in vivo rodent models of the nervous system.
Keywords: Bioluminescence (BL); Channelrhodopsin; Chemogenetics; Coelenterazine; Halorhodopsin; Luciferase; Luciferin; Luminopsins (LMOs); Optogenetics (OG); Step-function opsin (SFO).
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.